U.S. equities ended higher on Thursday as investors shifted toward healthcare and consumer stocks amid growing concerns about AI-related valuations and corporate debt exposure. The S&P 500 recovered from early losses, while the rotation highlighted a broader reassessment of market leadership as higher interest-rate concerns placed additional pressure on technology companies.

Healthcare Stocks Lead the Market Rebound

The S&P 500 rose 0.33%, while the Dow Jones Industrial Average gained 1.08% and the Nasdaq Composite advanced 0.08%. The recovery was driven in part by major healthcare companies, with drugmaker Eli Lilly gaining more than 3% and UnitedHealth rising 2.8%. Their gains made them significant contributors to the benchmark’s advance.

The move suggests that investors were seeking exposure to areas of the market viewed as less directly tied to the current AI investment cycle. Rather than abandoning equities broadly, traders appeared to be reallocating capital within the market as technology shares faced renewed scrutiny.

AI Debt Concerns Add Pressure to Technology Shares

Several technology stocks declined as investors examined the financial structures supporting the rapid expansion of artificial intelligence. In particular, companies carrying substantial AI-related debt loads may become more vulnerable if borrowing costs remain elevated or interest-rate expectations shift higher.

The concern comes as investors assess whether the enormous capital requirements associated with AI infrastructure can continue to support corporate growth and valuations. Rising financing costs can increase pressure on highly leveraged businesses, making debt levels an increasingly important factor in how investors evaluate companies participating in the AI expansion.

Chip Stocks Extend Their Losing Streak

The technology sector also faced pressure from continued weakness across semiconductor stocks. The chip index fell for a seventh consecutive session, extending a prolonged decline within a segment that has been central to the market’s AI-driven gains.

The semiconductor weakness contrasts with the relative strength in healthcare and consumer companies and reinforces the significance of the current sector rotation. Investors are increasingly weighing the sustainability of AI-related spending alongside broader macroeconomic developments, rather than treating technology exposure as a uniform market trade.

Inflation and TSMC Add to the Macro Picture

Thursday’s market moves also came against a backdrop of fresh inflation and corporate signals. U.S. producer prices rose in September by their largest amount in four and a half years, adding another consideration for markets already sensitive to interest-rate expectations. Higher producer costs can complicate the outlook for monetary policy and corporate margins if elevated pricing pressures persist.

Meanwhile, Taiwan Semiconductor Manufacturing Co. delivered its sixth consecutive record quarterly profit but struck a cautious tone regarding 2027. The combination of strong current AI-related demand and a more measured longer-term outlook provides an additional signal that investors are beginning to distinguish between near-term technology earnings strength and the durability of the broader AI investment cycle.

Going forward, markets are likely to remain sensitive to interest-rate expectations, inflation data and corporate debt levels, particularly among technology and AI-related companies. The performance of healthcare, consumer and other defensive sectors will also indicate whether Thursday’s rotation represents a short-term repositioning or a broader change in market leadership.